Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 06:18 am Purchase |
2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Corriente Advisors LLC | 2,000,000 5.660% |
2,000,000 (New Position) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Opaleye Management Inc. | 1,662,500 4.710% |
414,500 (+33.21%) |
Filing History |
| 2021-02-12 3:06 pm Purchase |
2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
JANUS HENDERSON GROUP PLC JHG |
2,137,671 6.100% |
2,137,671 (New Position) |
Filing History |
| 2021-02-11 12:55 pm Purchase |
2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
STATE STREET CORP STT |
2,548,772 7.220% |
2,548,772 (New Position) |
Filing History |
| 2021-02-10 4:46 pm Sale |
2021-01-31 | 13G | Cardiff Oncology, Inc. CRDF |
RA Capital Management, L.P. | 0 0.000% |
-3,290,000 (Position Closed) |
Filing History |
| 2021-02-01 6:10 pm Purchase |
2021-01-29 | 13G | Cardiff Oncology, Inc. CRDF |
Avidity Partners Management LP | 2,153,600 6.100% |
2,153,600 (New Position) |
Filing History |
| 2020-11-04 4:54 pm Purchase |
2020-10-08 | 13G | Cardiff Oncology, Inc. CRDF |
Venrock Healthcare Capital Partners III L.P. | 1,714,286 5.700% |
1,714,286 (New Position) |
Filing History |
| 2020-10-09 4:29 pm Purchase |
2020-09-30 | 13G | Cardiff Oncology, Inc. CRDF |
RA Capital Management, L.P. | 3,290,000 10.900% |
3,290,000 (New Position) |
Filing History |
| 2020-08-28 5:15 pm Purchase |
2020-08-19 | 13G | Cardiff Oncology, Inc. CRDF |
Opaleye Management Inc. | 1,248,000 5.370% |
1,248,000 (New Position) |
Filing History |
| 2020-07-02 2:59 pm Purchase |
2020-06-15 | 13D | Cardiff Oncology, Inc. CRDF |
ACORN BIOVENTURES, L.P. | 5,990,839 9.990% |
4,303,279 (+255.00%) |
Filing History |
| 2020-06-22 4:52 pm Purchase |
2020-06-15 | 13G | Cardiff Oncology, Inc. CRDF |
CAXTON CORP | 1,958,243 9.900% |
1,958,243 (New Position) |
Filing History |
| 2020-06-04 4:14 pm Purchase |
2020-05-27 | 13G | Cardiff Oncology, Inc. CRDF |
ACORN BIOVENTURES, L.P. | 1,687,560 9.990% |
1,687,560 (New Position) |
Filing History |